RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      유방재건술과 동시에 시행한 반대측 유방축소술 중 발견된 유방암 = Occult Breast Cancer in the Contralateral Reduction Mammaplasty Specimen in the Breast Reconstruction Patient

      한글로보기

      https://www.riss.kr/link?id=A104556724

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Contralateral reduction mammaplasty at the time of breast reconstruction using autogenous tissue gives aesthetically improved results in the patients with mammary hypertrophy or ptosis. It also reduces required flap size for reconstruction and permits discarding zones of poor perfusion, decreasing flap size- related problems such as partial flap loss or fat necrosis. Considering the high rate of bilaterality of breast cancer, it also provides a good opportunity for exploration and occult cancer diagnosis in such high risk group patients. Methods: We retrospectively reviewed 45 consecutive patients who underwent simultaneous breast reconstruction and contralateral reduction mammaplasty was performed about surgical technique, pathologic diagnosis, and subsequent treatment.Results: Three occult breast cancers were found in 45 patients(6.7%); one was microinvasive, and the other two were invasive carcinomas and their mean diameter was 1.2cm. One patient underwent subsequent breast conserving mastectomy, adjuvant radiation and chemotherapy. The others underwent only radiation and hormone therapy. They were followed up for 10 to 42 months without evidence of recurrence or metastasis. Conclusion: Occult breast cancer diagnosed in reduction mammaplasty specimen will lead to good prognosis due to its early detection. Treatment options depend on pathologic finding, stage, marginal status, and the timing of diagnosis. We recommend adequate markings for orientation and margins, excision with sufficient margin, and confirmation by frozen biopsy for suspected lesions.
      번역하기

      Purpose: Contralateral reduction mammaplasty at the time of breast reconstruction using autogenous tissue gives aesthetically improved results in the patients with mammary hypertrophy or ptosis. It also reduces required flap size for reconstruction an...

      Purpose: Contralateral reduction mammaplasty at the time of breast reconstruction using autogenous tissue gives aesthetically improved results in the patients with mammary hypertrophy or ptosis. It also reduces required flap size for reconstruction and permits discarding zones of poor perfusion, decreasing flap size- related problems such as partial flap loss or fat necrosis. Considering the high rate of bilaterality of breast cancer, it also provides a good opportunity for exploration and occult cancer diagnosis in such high risk group patients. Methods: We retrospectively reviewed 45 consecutive patients who underwent simultaneous breast reconstruction and contralateral reduction mammaplasty was performed about surgical technique, pathologic diagnosis, and subsequent treatment.Results: Three occult breast cancers were found in 45 patients(6.7%); one was microinvasive, and the other two were invasive carcinomas and their mean diameter was 1.2cm. One patient underwent subsequent breast conserving mastectomy, adjuvant radiation and chemotherapy. The others underwent only radiation and hormone therapy. They were followed up for 10 to 42 months without evidence of recurrence or metastasis. Conclusion: Occult breast cancer diagnosed in reduction mammaplasty specimen will lead to good prognosis due to its early detection. Treatment options depend on pathologic finding, stage, marginal status, and the timing of diagnosis. We recommend adequate markings for orientation and margins, excision with sufficient margin, and confirmation by frozen biopsy for suspected lesions.

      더보기

      참고문헌 (Reference)

      1 de Mascarel I, "The incidence of cancer in contralateral reduction mammaplasty after mastectomy and reconstruction of the removed breast" 30 : 183-, 1986

      2 Ozmen S, "Specimen radiography:an assessment method for reduction mammaplasty materials" 25 : 2001

      3 Lee TJ, "Simultaneous TRAM flap breast reconstruction with contralateral reduction mammoplasty" 31 : 2004

      4 Kakagia D, "Reduction mammaplasty specimens and occult breast carcinomas" 31 : 2005

      5 Butler CE, "Management of breast carcinoma identified intraoperatively during reduction mammaplasty" 50 : 2003

      6 Petit JY, "Contralateral mastoplasty for breast reconstruction:a good opportunity for glandular exploration and occult carcinomas diagnosis" 4 : 1997

      7 Tarone RE, "Breast reduction surgery and breast cancer risk: does reduction mammaplasty have a role in primary prevention strategies for women at high risk of breast cancer?" 113 : 2004

      8 Palmieri B, "Breast reduction and cancer in the gland remnant:a review" 91 : 2005

      9 Pitanguy I, "Breast pathology and reduction mammaplasty" 115 : 2005

      10 Keleher AJ, "Breast cancer in reduction mammaplasty specimens:case reports and guidelines" 9 : 2003

      1 de Mascarel I, "The incidence of cancer in contralateral reduction mammaplasty after mastectomy and reconstruction of the removed breast" 30 : 183-, 1986

      2 Ozmen S, "Specimen radiography:an assessment method for reduction mammaplasty materials" 25 : 2001

      3 Lee TJ, "Simultaneous TRAM flap breast reconstruction with contralateral reduction mammoplasty" 31 : 2004

      4 Kakagia D, "Reduction mammaplasty specimens and occult breast carcinomas" 31 : 2005

      5 Butler CE, "Management of breast carcinoma identified intraoperatively during reduction mammaplasty" 50 : 2003

      6 Petit JY, "Contralateral mastoplasty for breast reconstruction:a good opportunity for glandular exploration and occult carcinomas diagnosis" 4 : 1997

      7 Tarone RE, "Breast reduction surgery and breast cancer risk: does reduction mammaplasty have a role in primary prevention strategies for women at high risk of breast cancer?" 113 : 2004

      8 Palmieri B, "Breast reduction and cancer in the gland remnant:a review" 91 : 2005

      9 Pitanguy I, "Breast pathology and reduction mammaplasty" 115 : 2005

      10 Keleher AJ, "Breast cancer in reduction mammaplasty specimens:case reports and guidelines" 9 : 2003

      11 Tang CL, "Breast cancer found at the time of breast reduction" 103 : 1999

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-01-15 학술지명변경 한글명 : 대한성형외과 학회지 -> Archives of Plastic Surgery
      외국어명 : Journal of The Korean Society of Plastic and Reconstructive Surgeons -> Archives of Plastic Surgery
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.12 0.12 0.12
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.12 0.11 0.335 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼